Should You Buy Ionis Pharmaceuticals (IONS) After Golden Cross?

Core Viewpoint - Ionis Pharmaceuticals, Inc. (IONS) is showing potential as a stock pick due to a recent "golden cross" event, indicating a bullish trend reversal [1][4]. Technical Analysis - A "golden cross" occurs when a short-term moving average, specifically the 50-day, crosses above a long-term moving average, such as the 200-day, suggesting a potential bullish breakout [2]. - The formation of a golden cross typically follows three stages: a downtrend that bottoms out, the crossover of moving averages, and an upward price movement [3]. Performance Metrics - IONS has experienced a rally of 24.2% over the past four weeks, indicating strong momentum [4]. - The company currently holds a 3 (Hold) rating on the Zacks Rank, suggesting it may be positioned for further breakout potential [4]. Earnings Outlook - The earnings outlook for IONS is positive, with one upward revision in earnings estimates over the past 60 days, and the Zacks Consensus Estimate has also increased [4]. - Investors are encouraged to monitor IONS for potential gains, given its key technical levels and favorable earnings revisions [6].